Skip to main content
SpringerLink
Log in

Renal disease

  • Chapter
Clinical Nuclear Medicine

Abstract

The fundamental purpose of nephrourology is the preservation and improvement of renal function. The contribution that renal radionuclide studies makes to this goal is increasing in parallel with the developments in renal radiological techniques. This is through the application of renal ‘stress’ tests: frusemide-induced diuresis and captopril-enhanced determination of renovascular disorder; and because the sets of renal images are increasingly used as windows to analysis programs. These give objective measurements of two important renal functions: uptake function, the ability of each kidney to take up compounds from the blood leading to measurements of total and relative renal functions; and transit function, the time dependency of nephron transport which is utilized in the assessment of obstructive nephropathy and renovascular disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kiil, F. (1957) The Function of the Ureter and Renal Pelvis. Pressure Recordings and Radiographic Studies of the Normal and Diseased Upper Urinary Tract of Man, W.B. Saunders & Co., Philadelphia.

    Google Scholar 

  2. Sreenevasan, G. (1974) Bilateral renal calculi. Ann. R. Coll. Surg. Engl, 55, 3–12.

    PubMed  CAS  Google Scholar 

  3. Nimmon, C.C., Lee, T.Y., Britton, K.E. et al. (1981) Practical application of deconvolution techniques to dynamic studies, in Medical Radionuclide Imaging, Vol. I, International Atomic Energy Agency Vienna, pp. 367–88.

    Google Scholar 

  4. Britton, K.E., Nimmon, C.C., Whitfield, H.N. et al. (1979) Obstructive nephropathy: successful evaluation with radionuclides. Lancet, i, 905–7.

    Article  Google Scholar 

  5. Britton, K.E. and Brown, N.J.G. (1971) Clinical Renography, Lloyd Luke, London.

    Google Scholar 

  6. Britton, K.E. and Brown, N.J.G. (1971) The value in obstructive nephropathy of the hippuran output curve derived by computer analysis of the renogram, in The Proceedings of the International Symposium on Dynamic Renal Studies with Radioisotopes in Medicine, Vienna, International Atomic Energy Agency, pp. 263–75.

    Google Scholar 

  7. Rutland, M.D. (1985) A comprehensive analysis of renal DTPA studies. I. Theory and normal values. Nucl. Med. Commun., 6, 11–20.

    Article  PubMed  CAS  Google Scholar 

  8. Rutland, M.D. and Stuart, R.A. (1986) A comprehensive analysis of renal DTA studies II. Renal artery stenosis. Nucl. Med. Commun., 7, 879–85.

    Article  PubMed  CAS  Google Scholar 

  9. Peters, A.M., Gordon, I., Evans, K. et al. (1987) Background in the 99mTc-DTPA renogram: analysis of intravascular and extravascular components. Am. J. Physiol. Imaging, 2, 66–71.

    Google Scholar 

  10. Nimmon, C.C., Britton, K.E., Bomanji, J.B. et al. (1988) in Proceedings of the European Nuclear Medicine Congress (eds H.A.E. Schmidt and L. Csernay), Schattauer Verlag, Stuttgart, pp. 472–6.

    Google Scholar 

  11. Chaiwatanarat, T., Padhy, A.K., Bomanji, J.B. et al. (1993) Validation of renal output efficiency as an objective quantitative parameter in the evaluation of upper urinary tract obstruction. J. Nucl. Med., 34, 845–8.

    PubMed  CAS  Google Scholar 

  12. Peters, A.M. (1993) A unified approach to quantification by kinetic analysis in nuclear medicine. J. Nucl. Med., 34, 706–13.

    PubMed  CAS  Google Scholar 

  13. Peters, A.M. (1994) Graphical analysis of dynamic data the Patlak-Rutland plot. Nucl. Med. Commun., 15, 669–72.

    Article  PubMed  CAS  Google Scholar 

  14. Rutland, M.D. (1995) Tracer flows and difficult organs. Nucl. Med. Commun., 16, 31–7.

    Article  PubMed  CAS  Google Scholar 

  15. Fritzberg, A.R., Sudhaker, K., Eshima, D. et al. (1986) Synthesis and biological evaluation of Tc-99m MAG3 as a hippuran replacement. J. Nucl. Med., 17, 111–16.

    Google Scholar 

  16. Solanki, K.K., Al Nahhas, A. and Britton, K.E. (1989) Cold Tc-99m MAG3, in Trends and Possibilities in Nuclear Medicine (eds H.A.E. Schmidt and G.L. Buraggi), Schattauer Verlag, Stuttgart, pp. 443–6.

    Google Scholar 

  17. Bubeck, B., Brandau, W., Weber, E. et al. (1990) Pharmacokinetics of technetium-99m-MAG3 in humans. J. Nucl. Med., 31, 1285–93.

    PubMed  CAS  Google Scholar 

  18. Rehling, M., Nielsen, B.V., Pedersen, E.B. et al. (1995) Renal and extra renal clearance of 99mTc-MAGS: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate. Eur. J. Nucl. Med., 22, 1379–84.

    Article  PubMed  CAS  Google Scholar 

  19. Klingensmith, W.C., Briggs, D.E. and Smith, W.I. (1994) Technetium-99m MAG3 renal studies; normal range and reproducibility of physiologic parameters as a function of age and sex. J. Nucl. Med., 35, 1612–17.

    PubMed  Google Scholar 

  20. Jafri, R.A., Britton, K.E., Nimmon, C.C. et al. (1988) 99m-Tc MAG3: a comparison with 1–123 and 1–131 orthoiodohippurate in patients with renal disorder. J. Nucl. Med., 29, 147–58.

    PubMed  CAS  Google Scholar 

  21. Al-Nahhas, A.A., Jafri, R.A., Britton, K.E. et al. (1988) Clinical experience with 99mTc-MAG3, mercapto-acetyltriglycine and a comparison with 99mTc-DTPA. Eur. J. Nucl. Med., 14, 453–62.

    Article  PubMed  CAS  Google Scholar 

  22. Van Nerom, C., Bormans, C., Bauwens, J. et al. (1992) Comparative evaluation of Tc-99m LL ethylene dicysteine and Tc-99m MAG3 in volunteers. Eur. J. Nucl. Med., 33, 551–7.

    Google Scholar 

  23. Ozker, R., Onsel, C., Kabasakal, L. et al. (1994) Technetium-99m-N, N Ethylene dicysteine: a comparative study of renal scintigraphy with Technetium-99m MAG3 and iodine-131-OIH in patients with obstructive renal disease. J. Nucl. Med., 35, 840–5.

    PubMed  CAS  Google Scholar 

  24. Gupta, N.K., Bomanji, J.B., Waddington, W., Lui, D., Costa, D.C. and Verbruggen, A.M. (1995) Technetium-99m-L-L ethylene dicysteine scintigraphy in patients with renal disorders. Eur. J. Nucl. Med., 22, 617–24.

    Article  PubMed  CAS  Google Scholar 

  25. Kostadinova, I. and Simeonova, A. (1995) The use of 99mTc-EC Captopril test in patients with hypertension. Nucl. Med. Commun., 16, 128–31.

    PubMed  CAS  Google Scholar 

  26. Padhy, A.K., Solanki, K.K., Bomanji, J.B. et al. (1993) Clinical evaluation of mTc Diaminocyclohexane, a renal agent with cationic transport: results in healthy normal volunteers. Nephron, 65, 294–8.

    Article  PubMed  CAS  Google Scholar 

  27. Sonmezoglu, K., Demir, M., Erdil, T.Y. et al. (1995) Evaluation of renal function in patients with psoriasis on low dose cyclosporin regimen by using Tc-99m Diamino-cyclohexane (DACH). Eur. J. Nucl. Med., 22, 834.

    Google Scholar 

  28. Datseris, I., Boletis, J., Papadakis, E. et al. (1995) 99mTc-Diamino cyclohexane (DACH), a renal tubular agent with cationic transport excretion in renal transplant patients. Eur. J. Nucl. Med., 22, 835.

    Google Scholar 

  29. Peters, A.M., Jones, D.H., Evans, K. and Gordon, I. (1988) Two routes for 99m-Tc-DMSA uptake into the renal cortical tubular cell. Eur. J. Nucl. Med., 14, 555–61.

    Article  PubMed  CAS  Google Scholar 

  30. Yee, CA., Lee, H.B. and Blaufox, M.D. (1981) 99mTc DMSA renal uptake: influence of biochemical and physiological factors. J. Nucl. Med., 22, 1054–8.

    PubMed  CAS  Google Scholar 

  31. Williams, E., Parker, D. and Roy, R. (1986) Multiple-section radionuclide tomography of the kidney: a clinical evaluation. Br. J. Radiol., 59, 975–83.

    Article  PubMed  CAS  Google Scholar 

  32. Delcourt, E., Franken, P., Motte, S. et al. (1995) Measurement of glomerular filtration rate by means of a 99mTc DTPA complex and a scintillation camera: a method based on the kinetics of the distribution volume of the tracer in the kidney area. Nucl. Med. Commun., 6, 787–94.

    Google Scholar 

  33. Duffy, G.J., Casey, M. and Barker, F. (1982) in Radionuclides in Nephrology (eds A.M. Joekes, A.R. Constable, N.J.G. Brown and W.N. Tauxe), Academic Press, London, pp. 101–6.

    Google Scholar 

  34. Lee, T.Y., Constable, A.R. and Cranage, R.W. (1982) in Radionuclides in Nephrology (eds A.M. Joekes, A.R. Constable, N.J.G. Brown and W.N. Tauxe), Academic Press, London, pp. 107–12.

    Google Scholar 

  35. Rutland, M.D. (1983) Glomerular filtration rate without blood sampling. Nucl. Med. Commun., 4, 425–33.

    Article  Google Scholar 

  36. Shone, R.M., Koff, S.A., Mentser, M. et al. (1984) Glomerular filtration rate in children: determination from the Tc-99m DTPA renogram. Radiology, 151, 627–33.

    Google Scholar 

  37. Tonnesen, K.H., Munck, O., Hald, T. et al. (1975) in Radionuclides in Nephrology (eds K. Zum Winkel, M.D. Blaufox and J.L.F. Brentano), Georg Thieme, Stuttgart, pp. 79–86.

    Google Scholar 

  38. Goris, M.L., Daspit, S.G., McLaughlin, R. and Kriss, J.P. (1976) Interpolative background subtraction. J. Nucl. Med., 17, 744–7.

    PubMed  CAS  Google Scholar 

  39. Brown, N.J.G. (1982) in Radionuclides in Nephrology (eds A.M. Joekes, A.R. Constable, N.J.G. Brown and W.N. Tauxe), Academic Press, London, pp. 113–18.

    Google Scholar 

  40. Russell, C.D., Thorstad, B.L., Yester, M.B. et al. (1988) Quantitation of renal function with technetium-99m MAG3. J. Nucl Med., 29, 1931–3.

    PubMed  CAS  Google Scholar 

  41. Nimmo, M.J., Merrick, M.V. and Allan, P.L. (1987) Measurement of relative renal function: a comparison of methods and assessment of reproducibility. Br. J. Radiol, 60, 861–4.

    Article  PubMed  CAS  Google Scholar 

  42. Wujanto, R., Lawson, R.S., Prescott, M. et al. (1987) The importance of using anterior and posterior views in the calculation of differential renal function using 99mTc DMSA. Br. J. Radiol, 60, 869–72.

    Article  PubMed  CAS  Google Scholar 

  43. Britton, K.E. (1981) Essential hypertension: a disorder of cortical nephron control? Lancet, ii, 900–2.

    Article  Google Scholar 

  44. Al-Nahhas, A., Nimmon, C.C., Britton, K.E. et al. (1990). The effect of ramipril, a new angiotensin converting enzyme inhibitor on cortical nephron flow and effective renal plasma flow in patients with essential hypertension. Nephron, 54, 47–52.

    Article  PubMed  CAS  Google Scholar 

  45. Smith, H.W. (1951) The Kidney: Structure and Function in Health and Disease, Oxford University Press, Oxford.

    Google Scholar 

  46. Russell, C.D., Japanwalla, M., Khan, S., Scott, J.W. and Dubovsky, E.V. (1995) Techniques for measuring renal transit time. Eur. J. Nucl. Med., 22, 1372–8.

    Article  PubMed  CAS  Google Scholar 

  47. Makoba, G.I., Nimmon, C.C., Kouykin, V. et al. (1996) Comparison of a corticopelvic transfer index with renal transit times. Nucl. Med. Commun., 17, 212–15.

    Article  PubMed  CAS  Google Scholar 

  48. Mogensen, P., Munck, O. and Giese, J. (1995) 131I-hippuran renography in normal subjects and patients with essential hypertension. Scand. J. Clin. Invest., 35, 301–6.

    Google Scholar 

  49. Giese, J., Mogensen, P. and Munck, O. (1975) Diagnostic value of renography for detection of unilateral renal or renovascular disease in hypertensive patients. Scand. Clin. Lab. Invest., 35, 307–10.

    Article  CAS  Google Scholar 

  50. Nordyke, R.A., Gilbert, F.I. and Simmons, E.C (1969) Screening for kidney diseases with radioisotopes. JAMA, 208, 493–8.

    Article  PubMed  CAS  Google Scholar 

  51. Blaufox, M.D., Middleton, M.L., Bongiovanne, J. and Davis, B.R. (1996) Cost efficacy of the diagnosis and therapy of renovascular hypertension. J. Nucl Med., 37, 171–7.

    PubMed  CAS  Google Scholar 

  52. Al-Nahhas, A., Marcus, A.J., Bomanji, J. et al (1989) Validity of the mean parenchymal transit time as a screening test for the detection of functional renal artery stenosis in hypertensive patients. Nucl. Med. Commun., 10, 807–15.

    Article  PubMed  CAS  Google Scholar 

  53. Smith, H.W. (1956) Unilateral nephrectomy in hypertensive disease. J. Urol. 76, 685–701.

    PubMed  CAS  Google Scholar 

  54. Luke, R.G., Kennedy, A.C., Briggs, J.D. et al. (1968) Result of nephrectomy in hypertension associated with unilateral renal disease. Br. Med. J., 3, 764–8.

    Article  PubMed  CAS  Google Scholar 

  55. Datseris, I.E., Sonmezoglu, K., Siraj, Q.H. et al. (1995) Predictive value of Captopril transit renography in essential hypertension and diabetic nephropathy. Nucl. Med. Commun., 16, 4–9.

    Article  PubMed  CAS  Google Scholar 

  56. Oei, H.Y., Hoogeveen, E.K., Kooij, P.P.M. et al. (1994) Sensitivity of Captopril renography for detecting renal artery stenosis based on visual evaluation of sequential images performed with 99mTc-MAG3, in Radionuclides in Nephrourology (eds P.H. O’Reilly, A. Taylor and J.V. Nally), Field and Wood, Philadelphia, pp. 43–50.

    Google Scholar 

  57. Fommei, E., Ghione, S., Hilson, A.J.W. et al. (1993) Captopril radionuclide test in renovascular hypertension: a European multicentre study. Eur. J. Nucl. Med., 20, 635–44.

    Article  Google Scholar 

  58. Nally, J.W., Chen, C., Fine, E. et al. (1991) Diagnostic criteria of renovascular hypertension with Captopril renography. Am. J. Hypertension, 4, S749–52.

    Article  Google Scholar 

  59. Taylor, A. and Nally, J.V. (1995) Clinical applications of renal scintigraphy. Am. J. Radiol, 164, 31–41.

    Google Scholar 

  60. Taylor, A. and Nally, J.V. (1996) Consensus report on ACE inhibitor renography for the detection of renovascular hypertension. J. Nucl Med., 37, 1876–82.

    PubMed  CAS  Google Scholar 

  61. Maxwell, M.H., Marks, L.S., Varady, P.D. et al. (1975) Renal vein renin in essential hypertension. J. Lab. Clin. Med., 86, 901–9.

    PubMed  CAS  Google Scholar 

  62. Datseris, I.E., Bomanji, J.B., Brown, E.A. et al. (1994) Captopril renal scintigraphy in patients with hypertension and chronic renal failure. J. Nucl. Med., 35, 251–4.

    PubMed  CAS  Google Scholar 

  63. Blaufox, M.D. (1994) Should the role of Captopril renography extend to the evaluation of chronic renal disease? J. Nucl. Med., 35, 254–6.

    PubMed  CAS  Google Scholar 

  64. Britton, K.E., Bomanji, J.B., Datseris, I.E. et al. (1997) Captopril renal radionuclide studies in diabetic nephropathy, in Radionuclide Studies in Nephrology, Santa Fe Symposium 1995 (eds A. Taylor, J.V. Nally and M.D. Blaufox) (in press).

    Google Scholar 

  65. Farto, A., Soriano, A., Rinon, A. et al. (1996) Detection of renovascular hypertension with isotopic techniques; a comparison between basal, post-captopril and post aspirin renography, in Radiopharmaceuticals in Nephro Urology (eds G.S. Lemouris and M.M. Melloul), Mediterra Publishers, Athens, pp. 99–103.

    Google Scholar 

  66. O’Reilly, P., Aurell, M., Britton, K.E. et al. (1996) Consensus in diuresis renography. J. Nucl. Med., 37, 1872–6.

    PubMed  Google Scholar 

  67. Whitaker, R.M. (1979) An evaluation of 170 diagnostic pressure flow studies of the upper urinary tract. J. Urol, 121, 602–4.

    PubMed  CAS  Google Scholar 

  68. Whitfield, H.N., Britton, K.E., Hendry, W.F. et al. (1979) Frusemide intravenous urography in the diagnosis of pelviureteric junction obstruction. Br. J. Urol, 51, 445–8.

    Article  PubMed  CAS  Google Scholar 

  69. Kletter, K. and Nurnberger, N. (1989) Diagnostic potential of diuresis renography: limitations by the severity of hydronephrosis and by impairment of renal function. Nucl. Med. Commun., 10, 51–61.

    Article  PubMed  CAS  Google Scholar 

  70. Britton, K.E., Nawaz, M.K., Whitfield, H.N. et al. (1987) Obstructive nephropathy: comparison between parenchymal transit time index and frusemide diuresis. Br. J. Urol., 59, 127–32.

    Article  PubMed  CAS  Google Scholar 

  71. O’Reilly, P.H., Testa, H.J., Lawson, R.S., Farrar, D.J. and Charlton Edwards, E. (1978) Diuresis renography in equivocal urinary tract obstruction. Br. J. Urol., 50, 76–80.

    Article  PubMed  Google Scholar 

  72. O’Reilly, P.H., Lawson, R.S., Shields, R.A. and Testa, H.J. (1979) Idiopathic hydronephrosis J. Urol., 121, 153–5.

    PubMed  Google Scholar 

  73. O’Reilly, P.H. (1986) The diuresis renogram 8 years on: an update. J. Urol., 136, 993–9.

    PubMed  Google Scholar 

  74. Bahar, T.H. (1988) Chronic urinary schistosomiasis: patterns of abnormalities in radionuclide Tc-99m-DTPA diuretic renogram. Acta Pathol Microbiol Immunol Scand. Suppl., 54–58.

    Google Scholar 

  75. Bahar, R.H., Kouris, K., Sabha, X. et al. (1989) Value of quantitative analysis of radionuclide diuretic renogram in predicting the outcome of surgery in chronic schistosomal obstructive uropathy, in Dynamic Functional Studies in Nuclear Medicine in Developing Countries, International Atomic Energy Agency, Vienna, pp. 141–6.

    Google Scholar 

  76. Monsour, M., Azmy, A.F. and MacKenzie, J.R. (1987) Renal scarring secondary to vesicoureteric reflux: critical assessment and new grading. Br. J. Urol, 70, 320–4.

    Article  Google Scholar 

  77. Smellie, J.M., Shaw, P.J., Prescod, N.P. and Bantock, H.M. (1988) 99mTc dimercaptosuccinic acid (DMSA) scan in patients with established radiological renal scarring. Arch. Dis. Child., 63, 1315–19.

    Article  PubMed  CAS  Google Scholar 

Further Reading

  • Limouris, G.S., Melloul, M.M., Shukla, S.K. and Biersack, H.-J. (eds) (1996) Radiopharmaceuticals for Nephro Urology, Current status and Future Aspects, Mediterra Publishers, Athens.

    Google Scholar 

  • Taylor, A. and Blaufox, M.D. Radionuclides in Nephrology, Santa Fe Symposium, Society of Nuclear Medicine, New York (in press).

    Google Scholar 

Download references

Authors
  1. K. E. Britton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. N. Maisey
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Radiological Sciences, Guy’s and St Thomas’ Hospital, London, UK

    M. N. Maisey BSc MD FRCR FRCP

  2. Department of Nuclear Medicine, St Bartholomew’s Hospital, London, UK

    K. E. Britton MD MSc FRCR FRCP

  3. Nuclear Medicine Department, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    B. D. Collier BA MA MD

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Britton, K.E., Maisey, M.N. (1998). Renal disease. In: Maisey, M.N., Britton, K.E., Collier, B.D. (eds) Clinical Nuclear Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3356-0_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-3356-0_30

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-412-75180-6

  • Online ISBN: 978-1-4899-3356-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation